Biotechnology and genetic engineering in the new drug development. Part III. Biocatalysis, metabolic engineering and molecular modelling.

Journal Title: Pharmacological Reports - Year 2013, Vol 65, Issue 5

Abstract

Industrial biotechnology has been defined as the use and application of biotechnology for the sustainable processing and production of chemicals, materials and fuels. It makes use of biocatalysts such as microbial communities, whole-cell microorganisms or purified enzymes. In the review these processes are described. Drug design is an iterative process which begins when a chemist identifies a compound that displays an interesting biological profile and ends when both the activity profile and the chemical synthesis of the new chemical entity are optimized. Traditional approaches to drug discovery rely on a stepwise synthesis and screening program for large numbers of compounds to optimize activity profiles. Over the past ten to twenty years, scientists have used computer models of new chemical entities to help define activity profiles, geometries and relativities. This article introduces inter alia the concepts of molecular modelling and contains references for further reading.

Authors and Affiliations

Agnieszka Stryjewska, Katarzyna Kiepura, Tadeusz Librowski, Stanisław Lochyński

Keywords

Related Articles

Bismuth increases hydroxyl radical-scavenging activity of histamine H(2)-receptor antagonists.

The effects of histamine H(2)-receptor antagonists, alone or in a combination with bismuth, on ( )OH-provoked degradation of deoxyribose were studied. The histamine H(2)-receptor antagonists (cimetidine, ranitidine and r...

Possible contribution of IGF-1 to depressive disorder.

Depression is an illness of unknown origin and involves the dysregulation of many physiological processes disturbed in this disease. It has been postulated that the pathomechanism of depression is complex, and apart from...

Therapeutic potential of the biscoclaurine alkaloid, cepharanthine, for a range of clinical conditions.

Cepharanthine (CEP) is a naturally occurring alkaloid extracted from the plant Stephania cepharantha Hayata. It has been widely used in Japan for more than 40 years to treat a wide variety of acute and chronic diseases....

Renal vascular cytochrome P450-derived eicosanoids in androgen-induced hypertension.

Androgen has been linked to higher incidence of cardiovascular disease based on the simple observation that men have more cardiovascular and renal events than women at similar ages. The Cytochrome P450 (CYP)-derived eico...

Interleukin-1 (IL-1) in stress-induced activation of limbic-hypothalamic-pituitary adrenal axis.

Proinflammatory cytokine interleukin-1 (IL-1) produced during psychological and immunological stress, plays a significant role in the neuroendocrine and stress responses. Brain IL-1 is an important mediator in stress-ind...

Download PDF file
  • EP ID EP93874
  • DOI -
  • Views 74
  • Downloads 0

How To Cite

Agnieszka Stryjewska, Katarzyna Kiepura, Tadeusz Librowski, Stanisław Lochyński (2013). Biotechnology and genetic engineering in the new drug development. Part III. Biocatalysis, metabolic engineering and molecular modelling.. Pharmacological Reports, 65(5), 1102-1111. https://europub.co.uk/articles/-A-93874